Isabelle Soerjomataram
Oncology · 2008–2025
A researcher in the Science corpus: 30 papers; trusts 7 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 182 citations into it; #379 of 1,698 by trust here, #70 by citations
- Epidemiology — 114 citations into it
- Sociology and Political Science — 9 citations into it
Whom Isabelle Soerjomataram trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Isabelle Soerjomataram overall
Papers from Isabelle Soerjomataram's perspective
Ordered by how strongly the researchers Isabelle Soerjomataram trusts endorse each paper. Same corpus, a different order for every researcher.
- Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. (Journal of Infectious Diseases)
- A review of human carcinogens--Part B: biological agents. (The Lancet Oncology)
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer (International Journal of Cancer)
- Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. (The Lancet Oncology)
- Counting the dead and what they died from: an assessment of the global status of cause of death data. (Bulletin of the World Health Organization)
- International variation in prostate cancer incidence and mortality rates. (European Urology)
- Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study (British medical journal)
- Global patterns and trends in colorectal cancer incidence and mortality (Gut)
- Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (PLoS Medicine)
Their papers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2018) — 74,806 citations
- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) — 1,312 citations
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods (2018) — 6,627 citations
- Global patterns and trends in breast cancer incidence and mortality across 185 countries (2025) — 919 citations
- The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide (2024) — 746 citations
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024) — 29,832 citations
- Current and future burden of breast cancer: Global statistics for 2020 and 2040 (2022) — 2,868 citations
- The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020. (2022) — 975 citations
- The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study (2022) — 658 citations
- Global burden of primary liver cancer in 2020 and predictions to 2040 (2022) — 1,853 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries (2021) — 96,839 citations
- Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070 (2021) — 835 citations
- The ever‐increasing importance of cancer as a leading cause of premature death worldwide (2021) — 2,134 citations
- Cancer statistics for the year 2020: An overview (2021) — 4,841 citations
- Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. (2019) — 1,182 citations
- Global patterns and trends in colorectal cancer incidence in young adults (2019) — 788 citations
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. (2018) — 2,231 citations
- Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States (2018) — 1,440 citations
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. (2017) — 2,286 citations
- The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 (2017) — 692 citations